European women's imaging market growing

The European women's healthcare imaging market produced $455 million in revenues in 2006, and is expected to reach $647.1 million in 2013, according to market research and consulting firm Frost & Sullivan.

Despite issues related to reimbursement policies, high prices, and intensified competition, the market is growing, driven by the twin drivers of a rapidly aging population and replacement demand, according to the San Jose-based firm.

The mammography market is in the growth stage of the product life cycle, being spurred primarily due to the announcement of the Digital Mammographic Imaging Screening Trial (DMIST) results and the resultant digital transition across Europe, according to Frost & Sullivan. Bone densitometry systems are projected to experience low but stable revenue growth.

Among the limiting factors are the high costs of digital mammography systems and axial DEXA bone densitometry systems, which will inhibit market expansion, as will the high costs of bone densitometry screening and intense competition in the mammography systems market, according to the firm. In addition, these challenges will be exacerbated by varied country-specific reimbursement regulations, the company said.

By staff writers
February 14, 2007

Related Reading

Frost forecasts EHR, clinical trial application convergence, January 23, 2007

European ultrasound market heats up, December 19, 2006

Eastern European PACS market to expand, December 5, 2006

Study: U.S. MR market hits $1.4 billion, December 1, 2006

Worldwide ultrasound market will reach $4.5 billion, October 25, 2006

Copyright © 2007

Page 1 of 570
Next Page